Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Curr Microbiol ; 75(6): 726-735, 2018 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-29368026

RESUMEN

Fungi have a complex role in the intestinal tract, influencing health and disease, with dysbiosis contributing to obesity. Our objectives were to investigate fungal diversity in human gut microbiota among eutrophic, overweight, and obese. Epidemiological and nutritional information were collected from adult individuals, as well as stool samples processed for selective fungi isolation and identification by matrix-assisted laser desorption ionization time-of-flight mass spectrometry (yeasts) or microculture (filamentous fungi). Further 18S rDNA sequencing was performed to confirm identification. The mean count of fungi was 241 CFU/g of feces. Differences in the population level of the filamentous fungi were observed within eutrophic and obese groups. Overall, 34 genera were identified. The predominant phylum was Ascomycota with 20 different genera, followed by Basidiomycota and Zygomycota. As for Ascomycota, the most prevalent species were Paecilomyces sp., Penicillium sp., Candida sp., Aspergillus sp., Fonsecaea sp., and Geotrichum sp. (76.39, 65.28, 59.72, 58.33, 12.50, and 9.72%, respectively). As for Basidiomycota, Trichosporon sp. and Rhodotorula sp. were the most prevalent (30.56 and 15.28%, respectively), and for Zygomycota, Rhizopus sp. and Mucor sp. were the most numerous (15.28 and 9.72%, respectively). As expected there is a mycobiota shift towards obesity, with slightly higher diversity associated to eutrophic individuals. This mycobiota shift seems also to be related to the nutritional behavior of the individuals, as observed that the macronutrients intake may be positively related to the different fungi occurrences. Other studies are needed to better understand relationships between mycobiota and obesity, which could be used in future obesity treatments.


Asunto(s)
Ascomicetos/aislamiento & purificación , Aspergillus/aislamiento & purificación , Basidiomycota/aislamiento & purificación , Microbioma Gastrointestinal/fisiología , Obesidad/microbiología , Sobrepeso/microbiología , Penicillium/aislamiento & purificación , Ascomicetos/genética , Aspergillus/genética , Basidiomycota/genética , Heces/microbiología , Microbioma Gastrointestinal/genética , Humanos , Obesidad/genética , Sobrepeso/genética , Penicillium/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA